FRANKLIN LAKES, N.J. (Sept. 12, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today expanded their Class I voluntary recall initiated in the United States on July 8, 2025 and expanded on July 17, 2025 to inform customers of worst-case performanc
Similar Posts
GFA Production (Xiamen) Co., Ltd. Issues Voluntary Nationwide Recall of Easy Care First Aid® Burn Cream and First Aid Kits Due to Microbial Contamination
Xiamen, Fujian, GFA Production (Xiamen) Co., Ltd. is voluntarily recalling one lot of Easy Care first aid® AfterBurn® Cream, 0.9 g single-use packets. The single use packets are sold in boxes of 10 or packaged in certain First Aid kits. This recall is to the consumer level. FDA analysis found the pOasis Medical, Inc. – 707198 – 07/15/2025
CGMP/Finished Pharmaceuticals/AdulteratedVITAFER-L Gold 20ml may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use VITAFER-L Gold 20ml, a product promoted for energy and sexual enhancement on various websites, including www.amazon.com.CDER Manual of Policies & Procedures | MAPP
CDER’s Manual of Policies and Procedures (MAPPs) are federal directives and documentation of internal policies and procedures.Dr. Reddy’s Laboratories Limited – 7/18/2025
Dr. Reddy’s Laboratories Limited – 7/18/2025. Country: India. Record Type: 483Devalingam Mahalingam, M.D., Ph.D. – 721145 – 12/11/2025
Clinical Investigator